Future directions in Allogeneic Stem Cell Transplantation

Start date: 26 January 2012
End date:  - 28 January 2012
Start time: 07:00 pm
End time: 01:00 pm
Location: Medizinische Hochschule, Lecture Hall D


"Future directions in Allogeneic Stem Cell Transplantation"

which will take place 26. – 28. Januar 2012 in Lecture Hall D
Leader: Prof. Ganser and Prof. Sauer


Rainer Storb – Seattle, USA
Combined organ- and stem cell transplantation in the dog

Alois Gratwohl – Basel, Switzerland
Transplantation activities in Europe and worldwide - lessons to learn

XJ Huang – Beijing, China
Haploidentical stem cell transplantation

Andrea Velardi – Perugia, Italy
The role of NK cells in haploidentical stem cell transplantation

Rupert Handgretinger – Tübingen, Germany
Haploidentical stem cell transplantation in children with malignancies

Hermann Einsele - Würzburg, Germany
Antigen specific T-cell therapy to combat infection

Ernst Holler – Regensburg, Germany
Pathophyisology of Graft versus Host disease

Hildegard Greinix – Vienna, Austria
The role of B-cells in Graft versus Host disease

Eva Mischak-Weissinger - Hannover, Germany
Proteomics for the prediction of graft-versus-host disease

Christian Könecke - Hannover, Germany
Interferon-gamma production by allogeneic FoxP3+ regulatory T cells promotes survival in experimental GVHD

Anke Franzke – Hannover, Germany
Human regulatory T cells in allogeneic stem cell transplantation

Jürgen Finke – Freiburg, Germany
Anti-T-cell globulin in the prophylaxis of graft-versus-host disease

Cantz, Tobias – Hannover, Germany
Liver regeneration using induced pluripotent stem cells

Jürgen Krauter – Hannover, Germany
Molecular markers for the selection of AML patients for stem cell transplantation

Nicolaus Kröger – Hamburg, Germany
Stem cell transplantation for myeloproliferative diseases

Stripecke, Renata - Hannover, Germany
Clinical perspective of immune regeneration with genetically programmed DCs

Hans Stauss – London, UK
WT-1 T-cell receptor transfer for antigen specific targeting of leukemia

Hans-Jochem Kolb – Munich, Germany
Donor Iymphocyte infusions to boost the Graft-versus-Leukemia effect

Chiara Bonini – Milano, Italy
Genetic modifications of donor lymphocyte infusions

Christopher Baum - Hannover, Germany
Genetic modification of stem cells

Laurence Cooper - Houston, USA
Chimeric Antigen Receptors (CARs) on T cells

Lothar Hambach – Hannover, Germany
Exploitation of HA-1 mismatches for the prevention of leukemia relapse

Ulrike Köhl – Frankfurt, Germany 
Retargeting and activation of NK cells for cellular cancer immunotherapy post SCT 

Martin Sauer – Hannover, Germany 
 Challenges and promises of targeted contrast agent design for cellular therapeutics 

Hans Messner – Toronto, Canada 
 Future directions in allogenic stem cell transplantation

This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree